In recent years, 5Amino1MQ Peptide (abbreviated as 5Amino1MQ), a highly selective smallmolecule peptide inhibitor targeting nicotinamide Nmethyltransferase (NNMT), has exhibited broad application prospects and become a research hotspot in obesity and adipose tissue research due to its unique mechanism, favorable targeting ability, and safety
They involve injecting a solution containing various vitamins, such as vitamin C, vitamin B12, and others, into a muscle (intramuscular injection) or a vein (intravenous injection)
However, it is important to note that neurological symptoms can occur even in the absence of anaemia, particularly in patients taking folic acid supplements, which can mask the blood changes whilst neurological damage progresses
Phosphate-Buffered Saline (PBS): Maintains stable physiological pH (approximately 7.4) with appropriate ionic strength
Possible side effects are not well defined because no controlled human safety trial exists
Detailed Product Description 5-Amino-1-Methylquinolinium (5-Amino-1MQ) is a first-in-class, selective NNMT inhibitor designed for research into metabolic regulation, obesity, diabetes, nonalcoholic fatty liver disease, and age-associated muscle degeneration